Published in Ital J Surg Sci on January 01, 1983
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer (1987) 1.23
Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene (1991) 2.44
Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences. Eur J Cancer (1993) 1.66
Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer (1994) 1.36
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res (1997) 1.05
Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Am J Pathol (1992) 1.05
Endoparasites of red fox (Vulpes vulpes) in central Italy. J Wildl Dis (2009) 0.97
Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol (1997) 0.96
Animal models in oral cancer research. Oral Oncol (2005) 0.91
Canine piroplasmosis in Italy: epidemiological aspects in vertebrate and invertebrate hosts. Vet Parasitol (2009) 0.89
[Postoperative fistulas after gastrectomy: risk factors in relation to incidence and mortality]. Minerva Chir (1996) 0.86
Changes in the concentration of uterine cytoplasmic oestrogen receptors induced by doxorubicin and methotrexate. J Endocrinol (1978) 0.83
Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis. Eur J Cancer Clin Oncol (1988) 0.83
Mitotane treatment for adrenocortical carcinoma: an overview. Minerva Endocrinol (2012) 0.82
Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114. Virchows Arch (1997) 0.81
Screening results in a family cancer clinic: five years experience. Anticancer Res (1994) 0.81
The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer: a multifactorial analysis. Eur J Cancer Clin Oncol (1986) 0.81
Endo-arterial regional injection of radioisotopes in the treatment of malignant tumours. Int J Appl Radiat Isot (1966) 0.81
Estrogen and progesterone receptors in the human vagina. J Endocrinol Invest (1985) 0.80
Morphology and genetics of a Babesia isolate from Capreolus capreolus. J Wildl Dis (2008) 0.80
The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol (1987) 0.80
Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Anticancer Res (1992) 0.79
Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives. J Endocrinol (1983) 0.77
Effects of long-term administration of high doses of medroxyprogesterone acetate on hormone receptors and target organs in the female rat. J Endocrinol (1984) 0.77
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas. Br J Cancer (2005) 0.77
Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res (1992) 0.76
Endoscopic follow-up after colorectal cancer resection: an Italian multicentre study. Dig Liver Dis (2005) 0.76
Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer. Int J Biol Markers (1995) 0.76
Perchloric acid-soluble proteins from goat liver inhibit chemical carcinogenesis of Syrian hamster cheek-pouch carcinoma. Br J Cancer (1999) 0.75
Regulation of uterine estrogen receptors (ER) by beta-adrenergic stimulation in immature rats. J Vet Pharmacol Ther (1993) 0.75
[Palliative demolitive surgery]. Minerva Med (1975) 0.75
[Endoarterial radioisotope therapy of tumors]. Cancro (1971) 0.75
[Anticancer therapy: the year was not lost]. Minerva Med (1972) 0.75
[Cancer: modern therapeutic concepts for the disease of the century]. Minerva Med (1969) 0.75
[The pharmacologic profile of flutamide]. G Ital Chemioter (1986) 0.75
[Experimental presuppositions on loco-regional infiltration of osseous neoplasms with preparations of P32]. Minerva Med (1967) 0.75
Radiating resin microspheres in the treatment of cancer: the endoarterial administration of 32p- and 51cr-labeled microspheres. Prog Clin Cancer (1970) 0.75
[Critical analysis of the conditions which cause persons to make voluntary visits to the detection centers. Statistical study of a decade of activity of the Center for early diagnosis of tumors at the Istituto di Oncologia of Turin]. Minerva Ginecol (1971) 0.75
Endoarterial chemotherapy in oral cancer. Trans Int Conf Oral Surg (1973) 0.75
[Inoculation of cells of the Walker tumor into the spleen of the rat. 3]. Minerva Chir (1968) 0.75
[49 interventions using the Wertheim-Meigs method in carcinoma of the uterine cervix]. Cancro (1973) 0.75
[Problems of hepatotoxocity of triacetyloleandomycin]. Med Chir Dig (1976) 0.75
Hypothalamic H1 and H2 receptors: a tool to investigate the neuroendocrine role of histamine. Pharmacol Res Commun (1980) 0.75
[The possibilities of the use of radioactive microspheres in intra-arterial administration in treatment of neoplasms of the extremities]. Minerva Ortop (1969) 0.75
[Intra-arterial therapy of tumors with radioactive isotopes: analysis of some cases]. Cancro (1970) 0.75
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors. Farmaco Sci (1980) 0.75
[Endoarterial radioactive microspheres in attempted therapy of urinary tract neoplasms]. Minerva Urol (1972) 0.75
[Ovariectomy with bilateral adrenalectomy for advanced cancer of the breast. 118 cases]. Presse Med (1971) 0.75
[Mechanism of action of progestins in the treatment of hormone-dependent breast cancer (author's transl)]. Tumori (1976) 0.75
[Usefulness of endoarterial therapy with radioactive microspheres in locally inoperable cancer of the breast]. Minerva Chir (1970) 0.75
[Arteriographic and scintillographic controls in regional intra-arterial therapy of malignant tumors with microspheres of radioactive resin]. Minerva Med (1966) 0.75
Results with 67Ga-citrate in tumor diagnosis. J Nucl Biol Med (1973) 0.75
[Thyroid scintigraphic findings at a distant period after thyroidectomy. Studies on 87 cases]. Cancro (1974) 0.75
Oxisuran metabolism in pigs. Drug Metab Dispos (1976) 0.75
[Use of endoarterial chemotherapy of the tumors. Critical notes]. Cancro (1971) 0.75
[Radical neck dissection in advanced tumors of the head and neck. Considerations on 52 cases]. Cancro (1974) 0.75
[Distribution of estrogen receptors and progesterone receptors in the human uterus and influence of anesthetic drugs]. Minerva Ginecol (1982) 0.75
[Long-term results in 93 cases of total hysterectomy for carcinoma of the uterine cervix]. Cancro (1974) 0.75
Production of casein and the presence of estrogen receptors in human breast cancer. J Natl Cancer Inst (1977) 0.75
[On intra-arterial antineoplastic chemotherapy]. Cancro (1970) 0.75
Effects of bromocriptine and dopamine on the binding of estradiol to its uterine cytoplasmic receptors. Pharmacol Res Commun (1983) 0.75
[Evaluation of 458 radical mastectomies]. Cancro (1973) 0.75
[Current limitations and possibilities of microspheres of resin labeled with P32 and Cr51]. Minerva Med (1967) 0.75
[Some reflections and long term results on the treatment of inoperable or recurrent tumors with radioisotopes administered via interstitial or endoarterial route]. Strahlentherapie Sonderb (1967) 0.75
[Toxicological study on methacycline]. Antibiotica (1968) 0.75
Urea increases serum albumin binding of drugs. J Pharm Pharmacol (1972) 0.75
Lactalbumin synthesis in breast-cancer tissue. Lancet (1977) 0.75
[Endoarterial therapy of cancer by radioactive resin microspheres]. Lyon Chir (1970) 0.75
[Considerations and limitations in the treatment of malignant tumors with endoarterial radioactive microspheres]. Minerva Chir (1971) 0.75
[The use of radioactive microspheres in intra-arterial administration in the treatment of pelvic tumors in advanced stages]. Minerva Ginecol (1969) 0.75
[Correlations between determinations of the hormone dependence of breast tumors and their treatment]. Minerva Chir (1976) 0.75
[The use of P32 in the surgical treatment of malignant oro-maxillofacial tumors]. Minerva Stomatol (1966) 0.75
[Inoculation of cells of the Walker tumor into the blood vessels of the rat. IV]. Minerva Chir (1968) 0.75
Preliminary experimental observations on endoarterial introduction of radiating resin microspheres. Int J Appl Radiat Isot (1968) 0.75
[Neoplasm incidence in the surgery of the aged. Analysis of cases]. Cancro (1974) 0.75
Enhancement of pentobarbital narcosis by drugs competing on the serum protein binding. Biochem Pharmacol (1971) 0.75
[On the development of the Walker tumor in the skin and subcutaneous tissue of the rat. I]. Minerva Chir (1968) 0.75
[On the Walker tumor: transplantability and metastasis. (Conclusive note)]. Minerva Chir (1968) 0.75
[Overall evaluation of the results of treatment of metastatic carcinomas of the breast with high doses of MAP combined with bromocryptin]. Minerva Med (1980) 0.75
Interference of gestagens and androgens with rat uterine oestrogen receptors. J Endocrinol (1978) 0.75
Interaction of estradiol and 2-hydroxy-estradiol with histamine receptors at hypothalamic level. Brain Res (1980) 0.75
[Influence of K-strophanthin on the rheological behavior of myosin and actin of skeletal and cardiac muscle]. Boll Soc Ital Biol Sper (1968) 0.75
[Preliminary results of treatment of hormone-dependent metastatic carcinoma of the breast with the bromocriptin-medroxyprogesterone acetate combination]. Minerva Med (1977) 0.75
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors. Chemioterapia (1985) 0.75
[General nutritional problems of patients subjected to interventions on the upper respiratory and digestive tracts]. Minerva Med (1978) 0.75
[Inoculation of suspensions of cells of the Walker tumor into the cardiac, pleural and peritoneal cavities of the rat. II]. Minerva Chir (1968) 0.75
Notes on the transplantability and dissemination of experimental Walker's sarcomas. Panminerva Med (1968) 0.75
[Arterial chemotherapy of tumors. Considerations on 159 cases]. Minerva Chir (1979) 0.75
[Influence of 2-bromo-alpha-ergocryptine on the action of some psychotropic drugs. Research on rat mammae]. Boll Soc Ital Biol Sper (1976) 0.75
The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer. Ital J Surg Sci (1985) 0.75
[Effect of radio-opaque substances and local anesthetics on ciliary motility of the rhino-pharyngo-esophageal mucosa of the frog]. Arch Monaldi (1973) 0.75
[Results of hepatic resection for metastasis]. Minerva Chir (1988) 0.75
[Interstitial infiltration of mammary cancers with colloidal P32. Study of its distribution]. Arch Sci Med (Torino) (1969) 0.75
Interferences of prazosin on the binding of dicumarol with serum proteins. Farmaco Prat (1978) 0.75
[Treatment of breast carcinoma by intra-arterial route with microspheres of radioactive resin]. Minerva Ginecol (1968) 0.75
[Treatment of cancer of the tongue with intra-arterial administration of radioactive microspheres]. Minerva Med (1968) 0.75
[Current status of cryotherapy in oncology]. Minerva Med (1970) 0.75